Lurbinectedin
CTO-IUSCCC-0891
Phase 2 small_molecule active
Quick answer
Lurbinectedin for Small Cell Lung Cancer ( SCLC ) is a Phase 2 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Small Cell Lung Cancer ( SCLC )
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active